Bioadaptives (BDPT) Invested Capital (2019 - 2025)
Historic Invested Capital for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to -$497804.0.
- Bioadaptives' Invested Capital rose 3592.13% to -$497804.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$497804.0, marking a year-over-year increase of 3592.13%. This contributed to the annual value of -$410669.0 for FY2024, which is 3859.24% up from last year.
- Bioadaptives' Invested Capital amounted to -$497804.0 in Q3 2025, which was up 3592.13% from -$274662.0 recorded in Q2 2025.
- In the past 5 years, Bioadaptives' Invested Capital registered a high of -$274662.0 during Q2 2025, and its lowest value of -$804763.0 during Q3 2022.
- In the last 5 years, Bioadaptives' Invested Capital had a median value of -$665286.0 in 2022 and averaged -$607797.2.
- As far as peak fluctuations go, Bioadaptives' Invested Capital crashed by 7766.48% in 2024, and later surged by 6563.4% in 2025.
- Bioadaptives' Invested Capital (Quarter) stood at -$535997.0 in 2021, then plummeted by 42.66% to -$764645.0 in 2022, then rose by 12.54% to -$668759.0 in 2023, then surged by 38.59% to -$410669.0 in 2024, then dropped by 21.22% to -$497804.0 in 2025.
- Its Invested Capital was -$497804.0 in Q3 2025, compared to -$274662.0 in Q2 2025 and -$579464.0 in Q1 2025.